NFKB2 and colorectal carcinoma: Our findings demonstrated a significant reduction in the expression of CD4, CD8, and granzyme B (GZMB) in Nfkb2‐overexpressing MC38 tumor tissues and CRC tumor samples with high NFKB2 expression (Figure 3H).